Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：198
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 氯丙嗪单抗 | 5643 |
| 西马特罗单抗 | 5590 |
| 孕酮单抗 | 5816 |
| 氯霉素（CAP）单抗 | 5741 |
| 红霉素单抗 | 5703 |
| 地克珠利单抗 | 5510 |
| 无色孔雀石绿（LMG）单抗 | 5753 |
| 雌二醇单抗 | 5401 |
| 孔雀石绿（MG）单抗 | 5913 |
| 双酚A单抗 | 5660 |
| 呋喃妥因代谢物（2-NPAHD）单抗 | 5558 |
| 己烯雌酚单抗 | 5550 |
| 莱克多巴胺（RAC）单抗 | 5718 |
| 林可霉素单抗 | 5829 |
| 抗青霉素受体单抗 | 5571 |
| 大观霉素单抗 | 5607 |
| 克伦特罗（CL）单抗 | 5822 |
| 沙拉沙星单抗(2H4) | 5651 |
| 磺胺对甲氧嘧啶（SMD）单抗 | 5823 |
| 磺胺类SAS单抗 | 5713 |